Panion & BF Biotech Inc
TWSE:1760

Watchlist Manager
Panion & BF Biotech Inc Logo
Panion & BF Biotech Inc
TWSE:1760
Watchlist
Price: 67 TWD -0.89% Market Closed
Market Cap: NT$5.7B

Operating Margin

14.2%
Current
Improving
by 3.1%
vs 3-y average of 11.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
14.2%
=
Operating Income
NT$289.2m
/
Revenue
NT$2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
14.2%
=
Operating Income
NT$289.2m
/
Revenue
NT$2B

Peer Comparison

Country Company Market Cap Operating
Margin
TW
Panion & BF Biotech Inc
TWSE:1760
5.8B TWD
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219.1B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.6B USD
Loading...
FR
Sanofi SA
PAR:SAN
94.4B EUR
Loading...

Market Distribution

Higher than 76% of companies in Taiwan
Percentile
76th
Based on 1 045 companies
76th percentile
14.2%
Low
-21 347.1% — 0.7%
Typical Range
0.7% — 11.5%
High
11.5% — 698%
Distribution Statistics
Taiwan
Min -21 347.1%
30th Percentile 0.7%
Median 5%
70th Percentile 11.5%
Max 698%

Panion & BF Biotech Inc
Glance View

Market Cap
5.7B TWD
Industry
Pharmaceuticals

Panion & BF Biotech, Inc. engages in the manufacturing and sales of medicines, cosmetics, and formula foods. The company is headquartered in Taipei City, Taipei. The company went IPO on 2004-06-14. The firm is also involved in the manufacture and sales of various kinds of cosmetics. The firm's products also include formula food, medical devices, animal drugs, pet drugs, feed and environmental health drugs. The firm also provides biotechnology services. The firm distributes its products in Taiwan market and to the mainland China, Hong Kong and Macau markets.

Intrinsic Value
64.99 TWD
Overvaluation 3%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
14.2%
=
Operating Income
NT$289.2m
/
Revenue
NT$2B
What is Panion & BF Biotech Inc's current Operating Margin?

The current Operating Margin for Panion & BF Biotech Inc is 14.2%, which is above its 3-year median of 11.1%.

How has Operating Margin changed over time?

Over the last 3 years, Panion & BF Biotech Inc’s Operating Margin has decreased from 16.8% to 14.2%. During this period, it reached a low of 7.4% on Sep 30, 2023 and a high of 18.6% on Mar 31, 2023.

Back to Top